clinical trials
Clinical research trials are studies conducted to test new and innovative treatments, medications, or medical interventions to determine their safety and effectiveness. During these sponsored studies, researchers carefully design a plan, called a protocol, which outlines how the study will be conducted and provides very close monitoring of results throughout the entire study. The primary goal of these trials is to evaluate how effective the studied treatment is, to determine any side effects and to promote new and alternative treatments. It's a collaborative effort between researchers, volunteers, and local healthcare professionals, all working towards advancing medicine and improving individual health outcomes.
Be part of the solution
By signing up for a clinical trial you’re taking a proactive role in your own healthcare, gaining access to new treatments, and contributing to the advancement of healthcare science. The process is simple – fill out an application for any current clinical research studies you feel you may be eligible for and one of our team members will contact you and guide you through the rest of the process.
-
Gain access to new research treatments before they are available to the general public.
-
Play an active role in your own healthcare while also helping others.
-
Save medical costs by participating in trials – no insurance is needed!
BENEFITS of participating in research studies include:
Compensation for time & travel paid at visit
No cost study-related exams and treatment
Access to new treatments before they are available to the public
Quality care focusing on your medical condition(s)
New treatment alternatives when standard treatments may be insufficient
phase 01.
I studies are the first in a series of clinical trials in which a new drug or treatment is tested on a human subject. These tests help researchers determine the best dosing, timing and administration for a new treatment and also provide insights into how the drug reacts with the body. There are many types of studies that are conducted at our clinics. Sometimes, a study is a combination of multiple study types
phase 02.
The Phase II of a clinical trial lets doctors know how safe a treatment is and how well it works. They will also be able to tell if the specific treatment fits your needs in treating your disease while closely monitoring safety and side effects.
phase 03.
Phase III of a clinical trial will test the safety and ability of a new treatment compared to standard therapy. This is achieved by closely monitoring, collecting, and comparing data from study groups.
phase 04.
Phase IV of a clinical trial continues to monitor and collect data of a new treatment over a longer period of time after it has been FDA approved. Long-term use and interaction with other treatments will continue to be
Currently enrolling Clinical Studies
Simply fill out an application for any current clinical research studies you feel you may be eligible for and one of our team members will contact you and guide you through the rest of the process.
-
WHO IS ELIGIBLE: Children age 2 to <12 years of age with Moderate to Severe Atopic Dermatitis
EXPECTED STUDY DURATION: 160 weeks
Compensation for your time and travel
-
WHO IS ELIGIBLE: Healthy Subjects and Subjects with Moderate-to-Severe Active Thyroid Eye Disease
EXPECTED STUDY DURATION: 48 weeks
Compensation for your time and travel
-
ABOUT: Pink Eye
WHO IS ELIGIBLE: All ages
EXPECTED STUDY DURATION: 3 visits over 8 days
Compensation for your time and travel
-
ABOUT: IgA Nephropathy is a kidney disorder characterized by the abnormal deposition of immunoglobulin A (IgA) in the kidneys.
WHO IS ELIGIBLE: Males/Females 18 years of age or older
EXPECTED STUDY DURATION: 17 visits over 104 weeks
Compensation for your time and travel
-
A study to evaluate the effectiveness of a once daily treatment for premenopausal women ages 18-49 with endometriosis and associated pain.
WHO IS ELIGIBLE: Premenopausal females 18 to 49 years of age, with documented diagnosis of Endometriosis and experiencing moderate to severe pain
EXPECTED STUDY DURATION: Approximately 18 months, must be able to attend 5 study visits in the 1st 3 months and then once every 3 months.
Compensation for your time and travel
-
ABOUT: A condition where the stomach empties slowly without ab identifiable underlying cause.
WHO IS ELIGIBLE: Adults with Idiopathic Gastroparesis
EXPECTED STUDY DURATION: 8 visits over 91 days
Compensation for your time and travel
-
About: A chronic inflammatory bowel disease (IBD) that causes inflammation and ulcers in the large intestine (colon).
WHO IS ELIGIBLE: Adult patients with Moderately to Severe Active Ulcerative Colitis
EXPECTED STUDY DURATION: 64 weeks
Compensation for your time and travel
-
WHO IS ELIGIBLE: Adults treated with direct oral anticoagulants or vitamin K antagonists and undergoing a single or multiple tooth extraction
EXPECTED STUDY DURATION: 6 visits over 15 days
Compensation for your time and travel
-
ABOUT: Genetic testing on pregnant females with a gestational time of 10 weeks or more.
WHO IS ELIGIBLE: Females with gestational age of 10 weeks or greater
EXPECTED STUDY DURATION: 3 visits over 8 months
Compensation for your time and travel
-
WHO IS ELIGIBLE: Adults and Adolescent participants with Covid-19 who are at high risk of progressing to severe illness
EXPECTED STUDY DURATION: 12 visits over 24 weeks
Compensation for your time and travel
-
WHO IS ELIGIBLE: Females aged 18 to 45 years inclusive seeking treatment for HMB
EXPECTED STUDY DURATION: 56 Days
Compensation for your time and travel
-
Item description